Low Expression of CLEC2B Indicates Poor Prognosis in Melanoma
Yanqiu Zhang, Yaling Li, Hongwei Yan Department of Dermatology, The First Hospital of China Medical University, Shenyang, 110001, People’s Republic of ChinaCorrespondence: Hongwei Yan, Department of Dermatology, The First Hospital of China Medical University, Shenyang, 110001, People’s Republic of C...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2023-02-01
|
| Series: | Clinical, Cosmetic and Investigational Dermatology |
| Subjects: | |
| Online Access: | https://www.dovepress.com/low-expression-of-clec2b-indicates-poor-prognosis-in-melanoma-peer-reviewed-fulltext-article-CCID |
| _version_ | 1797900955004436480 |
|---|---|
| author | Zhang Y Li Y Yan H |
| author_facet | Zhang Y Li Y Yan H |
| author_sort | Zhang Y |
| collection | DOAJ |
| description | Yanqiu Zhang, Yaling Li, Hongwei Yan Department of Dermatology, The First Hospital of China Medical University, Shenyang, 110001, People’s Republic of ChinaCorrespondence: Hongwei Yan, Department of Dermatology, The First Hospital of China Medical University, Shenyang, 110001, People’s Republic of China, Email hongweiyan@hotmail.comBackground: Melanoma is a highly malignant skin tumor with a poor prognosis. Identification of novel biomarkers might potentially reveal the underlying mechanisms of melanoma progression.Methods: We demonstrated the relationship between pan-cancer CLEC2B expression and melanoma samples in The Cancer Genome Atlas (TCGA) database. Next, the Kaplan-Meier plot and Cox regression analysis determined the prognostic value of CLEC2B in melanoma. Biological pathway enrichment was screened by Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Set Enrichment Analysis (GSEA), enabling the correlation analysis between the immune infiltration level and CLEC2B expression in melanoma. Our final claim was validated using qPCR, immunohistochemistry, Western blot, cell colony formation assays, ethynyldeoxyuridine (Edu) analysis, and cell Invasion assays.Results: Our study revealed that the high CLEC2B expression correlates with poor overall survival of melanoma patients. Moreover, a low expression of CLEC2B was found in the A375 cell line. In addition, CLEC2B has significant prognostic value in melanoma diagnosis, with an AUC of 0.896. Prognostic analysis showed the low expression of CLEC2B to be independently associated with melanoma patients. Moreover, the expression of CLEC2B was significantly correlated with B cells, eosinophils, macrophages, neutrophils, NK cells, T helper cells, Tregs, Th1 cells, Th17 cells, and Th2 cells. PCR and immunohistochemistry indicated CLEC2B to be significantly downregulated in melanoma. The cell colony formation assay showed CLEC2B knockout increased the proliferation of A375 cells.Conclusion: Our study established low levels of CLEC2B to be poor prognostic markers, enabling immunosuppressive cell infiltration in melanoma.Keywords: melanoma, CLEC2B, prognosis, immune infiltration, TCGA |
| first_indexed | 2024-04-10T08:54:14Z |
| format | Article |
| id | doaj.art-2cef6bcba96c48cb934df791e041ab39 |
| institution | Directory Open Access Journal |
| issn | 1178-7015 |
| language | English |
| last_indexed | 2024-04-10T08:54:14Z |
| publishDate | 2023-02-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Clinical, Cosmetic and Investigational Dermatology |
| spelling | doaj.art-2cef6bcba96c48cb934df791e041ab392023-02-21T18:00:13ZengDove Medical PressClinical, Cosmetic and Investigational Dermatology1178-70152023-02-01Volume 1646347781782Low Expression of CLEC2B Indicates Poor Prognosis in MelanomaZhang YLi YYan HYanqiu Zhang, Yaling Li, Hongwei Yan Department of Dermatology, The First Hospital of China Medical University, Shenyang, 110001, People’s Republic of ChinaCorrespondence: Hongwei Yan, Department of Dermatology, The First Hospital of China Medical University, Shenyang, 110001, People’s Republic of China, Email hongweiyan@hotmail.comBackground: Melanoma is a highly malignant skin tumor with a poor prognosis. Identification of novel biomarkers might potentially reveal the underlying mechanisms of melanoma progression.Methods: We demonstrated the relationship between pan-cancer CLEC2B expression and melanoma samples in The Cancer Genome Atlas (TCGA) database. Next, the Kaplan-Meier plot and Cox regression analysis determined the prognostic value of CLEC2B in melanoma. Biological pathway enrichment was screened by Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Set Enrichment Analysis (GSEA), enabling the correlation analysis between the immune infiltration level and CLEC2B expression in melanoma. Our final claim was validated using qPCR, immunohistochemistry, Western blot, cell colony formation assays, ethynyldeoxyuridine (Edu) analysis, and cell Invasion assays.Results: Our study revealed that the high CLEC2B expression correlates with poor overall survival of melanoma patients. Moreover, a low expression of CLEC2B was found in the A375 cell line. In addition, CLEC2B has significant prognostic value in melanoma diagnosis, with an AUC of 0.896. Prognostic analysis showed the low expression of CLEC2B to be independently associated with melanoma patients. Moreover, the expression of CLEC2B was significantly correlated with B cells, eosinophils, macrophages, neutrophils, NK cells, T helper cells, Tregs, Th1 cells, Th17 cells, and Th2 cells. PCR and immunohistochemistry indicated CLEC2B to be significantly downregulated in melanoma. The cell colony formation assay showed CLEC2B knockout increased the proliferation of A375 cells.Conclusion: Our study established low levels of CLEC2B to be poor prognostic markers, enabling immunosuppressive cell infiltration in melanoma.Keywords: melanoma, CLEC2B, prognosis, immune infiltration, TCGAhttps://www.dovepress.com/low-expression-of-clec2b-indicates-poor-prognosis-in-melanoma-peer-reviewed-fulltext-article-CCIDmelanomaclec2bprognosisimmune infiltrationtcga |
| spellingShingle | Zhang Y Li Y Yan H Low Expression of CLEC2B Indicates Poor Prognosis in Melanoma Clinical, Cosmetic and Investigational Dermatology melanoma clec2b prognosis immune infiltration tcga |
| title | Low Expression of CLEC2B Indicates Poor Prognosis in Melanoma |
| title_full | Low Expression of CLEC2B Indicates Poor Prognosis in Melanoma |
| title_fullStr | Low Expression of CLEC2B Indicates Poor Prognosis in Melanoma |
| title_full_unstemmed | Low Expression of CLEC2B Indicates Poor Prognosis in Melanoma |
| title_short | Low Expression of CLEC2B Indicates Poor Prognosis in Melanoma |
| title_sort | low expression of clec2b indicates poor prognosis in melanoma |
| topic | melanoma clec2b prognosis immune infiltration tcga |
| url | https://www.dovepress.com/low-expression-of-clec2b-indicates-poor-prognosis-in-melanoma-peer-reviewed-fulltext-article-CCID |
| work_keys_str_mv | AT zhangy lowexpressionofclec2bindicatespoorprognosisinmelanoma AT liy lowexpressionofclec2bindicatespoorprognosisinmelanoma AT yanh lowexpressionofclec2bindicatespoorprognosisinmelanoma |